Simplex Trading, LLC Arcellx, Inc. Transaction History

Simplex Trading, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	BUY	$31.75 - $57.99 $173,736 - $317,321	5,472 Added 60800.0%	5,481 $304,000
Q3 2023 Nov 01, 2023	BUY	$31.51 - $37.4 $283 - $336	9 New	9 $0
Q4 2022 Feb 02, 2023	SELL	$17.18 - $33.0 $56,212 - $107,976	-3,272 Reduced 85.01%	577 $17,000
Q3 2022 Nov 04, 2022	BUY	$16.67 - $22.04 $64,162 - $84,831	3,849 New	3,849 $72,000

205

44.2M

2.23M

907K

Ticker ACLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,819,200
Market Cap $3.85B
Description
Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.